Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia.

Ellingrod VL, Bishop JR, Moline J, Lin YC, Miller DD.

Psychopharmacol Bull. 2007;40(1):57-62.

PMID:
17285096
2.

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.

Ujike H, Nomura A, Morita Y, Morio A, Okahisa Y, Kotaka T, Kodama M, Ishihara T, Kuroda S.

J Clin Psychiatry. 2008 Sep;69(9):1416-22.

PMID:
19193342
3.
4.
5.

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.

Houston JP, Kohler J, Bishop JR, Ellingrod VL, Ostbye KM, Zhao F, Conley RR, Poole Hoffmann V, Fijal BA.

J Clin Psychiatry. 2012 Aug;73(8):1077-86. doi: 10.4088/JCP.11m06916.

PMID:
22967772
6.

Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain.

Kang SG, Lee HJ, Park YM, Choi JE, Han C, Kim YK, Kim SH, Lee MS, Joe SH, Jung IK, Kim L.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):160-3. Epub 2007 Aug 14.

PMID:
17804136
7.

Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.

Park YM, Choi JE, Kang SG, Koo SH, Kim L, Geum D, Lee HJ.

Hum Psychopharmacol. 2011 Jun-Jul;26(4-5):332-7. doi: 10.1002/hup.1210. Epub 2011 Jun 22.

PMID:
21695734
8.

Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.

Brandl EJ, Frydrychowicz C, Tiwari AK, Lett TA, Kitzrow W, Büttner S, Ehrlich S, Meltzer HY, Lieberman JA, Kennedy JL, Müller DJ, Puls I.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):134-41. doi: 10.1016/j.pnpbp.2012.03.001. Epub 2012 Mar 8.

PMID:
22426215
9.

Weight gain associated with the alpha2a-adrenergic receptor -1,291 C/G polymorphism and olanzapine treatment.

Park YM, Chung YC, Lee SH, Lee KJ, Kim H, Byun YC, Lim SW, Paik JW, Lee HJ.

Am J Med Genet B Neuropsychiatr Genet. 2006 Jun 5;141B(4):394-7.

PMID:
16583406
10.

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients.

Park YM, Cho JH, Kang SG, Choi JE, Lee SH, Kim L, Lee HJ.

J Clin Pharm Ther. 2008 Feb;33(1):55-60. doi: 10.1111/j.1365-2710.2008.00872.x.

PMID:
18211617
11.

Possible association of the pro-melanin-concentrating hormone gene with a greater body mass index as a side effect of the antipsychotic olanzapine.

Chagnon YC, Bureau A, Gendron D, Bouchard RH, Mérette C, Roy MA, Maziade M.

Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1063-9.

PMID:
17541984
12.

Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population.

Zhang XY, Tan YL, Zhou DF, Haile CN, Cao LY, Xu Q, Shen Y, Kosten TA, Kosten TR.

J Clin Psychopharmacol. 2007 Jun;27(3):246-51.

PMID:
17502770
13.

Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.

Tsuneyama N, Suzuki Y, Sawamura K, Sugai T, Fukui N, Watanabe J, Ono S, Saito M, Someya T.

PLoS One. 2016 Mar 1;11(3):e0149518. doi: 10.1371/journal.pone.0149518. eCollection 2016.

14.

The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia.

Lin YC, Ellingrod VL, Bishop JR, Miller DD.

Ther Drug Monit. 2006 Oct;28(5):668-72.

PMID:
17038883
15.

Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes.

Srivastava V, Deshpande SN, Nimgaonkar VL, Lerer B, Thelma B.

Pharmacogenomics. 2008 Aug;9(8):1055-68. doi: 10.2217/14622416.9.8.1055.

PMID:
18681781
16.

Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting.

Gregoor JG, van der Weide J, Loovers HM, van Megen HJ, Egberts TC, Heerdink ER.

Pharmacogenomics. 2011 Jun;12(6):919-23. doi: 10.2217/pgs.11.40. Epub 2011 Apr 21.

PMID:
21510767
17.

Weight gain during treatment of bipolar I patients with olanzapine.

Hennen J, Perlis RH, Sachs G, Tohen M, Baldessarini RJ.

J Clin Psychiatry. 2004 Dec;65(12):1679-87.

PMID:
15641874
18.

Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment.

Perez-Iglesias R, Mata I, Amado JA, Berja A, Garcia-Unzueta MT, Martínez García O, Arranz MJ, Vazquez-Barquero JL, Crespo-Facorro B.

J Clin Psychopharmacol. 2010 Dec;30(6):661-6.

PMID:
21105276
19.

HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.

Ma X, Maimaitirexiati T, Zhang R, Gui X, Zhang W, Xu G, Hu G.

Int J Psychiatry Clin Pract. 2014 Oct;18(4):229-42. doi: 10.3109/13651501.2014.957705. Epub 2014 Sep 18.

PMID:
25152019
20.

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B.

J Clin Psychiatry. 2003 May;64(5):598-604.

PMID:
12755665

Supplemental Content

Support Center